Bromomethane

Bromomethane

SCHEMBL5883756

CBr.O=C(O)NC(c1ccccc1)c1ccccc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.59
TSHR P16473 1/20 0.55
HPGDS O60760 2/20 0.52
ALDH1A1 P00352 3/20 0.50
RXFP1 Q9HBX9 1/20 0.50
MDM4 O15151 1/20 0.47
MAPT P10636 1/20 0.47
MDM2 Q00987 1/20 0.47
KMT2A Q03164 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CNR1 P21554 1/20 0.47
HPGD P15428 1/20 0.47
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.45
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1694742 0.93 LMNA (0.60) LMNATSHRHPGDSALDH1A1RXFP1
Hydrochloric Acid SCHEMBL5883141 0.91 LMNA (0.58) LMNATSHRHPGDSALDH1A1RXFP1
SCHEMBL5787782 0.86 CNR1 (0.65) LMNATSHRHPGDSALDH1A1KMT2A
SCHEMBL29902958 0.83 LMNA (0.51) LMNATSHRHPGDSALDH1A1RXFP1
SCHEMBL334423 0.82 ALDH1A1 (0.60) LMNATSHRHPGDSALDH1A1MAPT
SCHEMBL3827444 0.80 LMNA (0.53) LMNATSHRHPGDSALDH1A1RXFP1
SCHEMBL425361 0.80 ALDH1A1 (0.58) LMNATSHRHPGDSALDH1A1RXFP1
SCHEMBL24575947 0.79 HPGDS (0.57) LMNATSHRHPGDSALDH1A1KMT2A
SCHEMBL11336993 0.79 HPGDS (0.57) LMNATSHRHPGDSALDH1A1KMT2A
SCHEMBL14166017 0.79 HPGDS (0.52) LMNATSHRHPGDSALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7041674-B2 Carbamic acid esters with anticholinergic activity BOEHRINGER INGELHIEM PHARMA GMBH & CO. KG (DE) 2006-05-09 US disclosed
US-20040132760-A1 Carbamic acid esters with anticholinergic activity BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132760-A1 Carbamic acid esters with anticholinergic activity CHRM2, CHRM1, ACHE LMNA 2803/4885TSHR 702/4885HPGDS 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.